OA11598A - HIV vaccine. - Google Patents
HIV vaccine. Download PDFInfo
- Publication number
- OA11598A OA11598A OA1200100041A OA1200100041A OA11598A OA 11598 A OA11598 A OA 11598A OA 1200100041 A OA1200100041 A OA 1200100041A OA 1200100041 A OA1200100041 A OA 1200100041A OA 11598 A OA11598 A OA 11598A
- Authority
- OA
- OAPI
- Prior art keywords
- nss
- hiv
- cytolytic
- virus
- retrovirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9623598P | 1998-08-12 | 1998-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11598A true OA11598A (en) | 2004-07-30 |
Family
ID=22256483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200100041A OA11598A (en) | 1998-08-12 | 1999-08-12 | HIV vaccine. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1105498B1 (zh) |
| KR (1) | KR100689249B1 (zh) |
| CN (1) | CN1206355C (zh) |
| AP (1) | AP1561A (zh) |
| AT (1) | ATE431415T1 (zh) |
| AU (1) | AU5274099A (zh) |
| CA (1) | CA2339850C (zh) |
| DE (1) | DE69940886D1 (zh) |
| DK (1) | DK1105498T3 (zh) |
| ES (1) | ES2327300T3 (zh) |
| OA (1) | OA11598A (zh) |
| PT (1) | PT1105498E (zh) |
| WO (1) | WO2000009703A1 (zh) |
| ZA (1) | ZA200100941B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608273B2 (en) * | 1998-08-12 | 2009-10-27 | University Of Western Ontario | Recombinant lentivirus encoding modified GP 120 signal sequences |
| WO2005012535A2 (en) * | 2003-08-01 | 2005-02-10 | Phytovation B.V. | Method for producing life attenuated viruses and use of viral particles thus produced. |
| CN111701016A (zh) * | 2020-06-28 | 2020-09-25 | 张全志 | 逆转录病毒原病毒序列在逆转录病毒疫苗设计中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5848794A (en) * | 1993-02-05 | 1994-08-29 | Regents Of The University Of California, The | Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use |
-
1999
- 1999-08-12 PT PT99938094T patent/PT1105498E/pt unknown
- 1999-08-12 OA OA1200100041A patent/OA11598A/en unknown
- 1999-08-12 KR KR1020017001836A patent/KR100689249B1/ko not_active IP Right Cessation
- 1999-08-12 AP APAP/P/2001/002076A patent/AP1561A/en active
- 1999-08-12 DE DE69940886T patent/DE69940886D1/de not_active Expired - Lifetime
- 1999-08-12 AU AU52740/99A patent/AU5274099A/en not_active Abandoned
- 1999-08-12 CN CNB998108529A patent/CN1206355C/zh not_active Expired - Lifetime
- 1999-08-12 AT AT99938094T patent/ATE431415T1/de active
- 1999-08-12 EP EP99938094A patent/EP1105498B1/en not_active Expired - Lifetime
- 1999-08-12 WO PCT/CA1999/000746 patent/WO2000009703A1/en active IP Right Grant
- 1999-08-12 DK DK99938094T patent/DK1105498T3/da active
- 1999-08-12 CA CA2339850A patent/CA2339850C/en not_active Expired - Lifetime
- 1999-08-12 ES ES99938094T patent/ES2327300T3/es not_active Expired - Lifetime
-
2001
- 2001-02-02 ZA ZA200100941A patent/ZA200100941B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200100941B (en) | 2002-02-04 |
| CA2339850C (en) | 2011-10-04 |
| AP2001002076A0 (en) | 2001-03-31 |
| PT1105498E (pt) | 2009-08-13 |
| DE69940886D1 (en) | 2009-06-25 |
| EP1105498A1 (en) | 2001-06-13 |
| CN1318104A (zh) | 2001-10-17 |
| CA2339850A1 (en) | 2000-02-24 |
| CN1206355C (zh) | 2005-06-15 |
| WO2000009703A1 (en) | 2000-02-24 |
| ATE431415T1 (de) | 2009-05-15 |
| EP1105498B1 (en) | 2009-05-13 |
| KR100689249B1 (ko) | 2007-03-08 |
| ES2327300T3 (es) | 2009-10-27 |
| AU5274099A (en) | 2000-03-06 |
| KR20010072436A (ko) | 2001-07-31 |
| AP1561A (en) | 2006-02-01 |
| DK1105498T3 (da) | 2009-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210317169A1 (en) | Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using same | |
| Shafferman et al. | Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. | |
| US20030158134A1 (en) | Vaccine for the prophylactic or therapeutic immunization against hiv | |
| Johnson et al. | Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. | |
| Burgers et al. | Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial | |
| US20040191269A1 (en) | Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods | |
| NZ525751A (en) | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV | |
| PUTKONEN et al. | Vaccine protection against HIV-2 infection in cynomolgus monkeys | |
| KR20100109555A (ko) | 백신 | |
| US7067134B1 (en) | HIV vaccine | |
| Boeri et al. | In vivo genetic variability of the human immunodeficiency virus type 2 V3 region | |
| US20040223977A1 (en) | Fusion peptide HIV vaccines | |
| CA2304125A1 (en) | Attenuated vif dna immunization cassettes for genetic vaccines | |
| KR101370817B1 (ko) | Ｈｉｖ 백신 | |
| US5876724A (en) | Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein | |
| US20070099276A1 (en) | Retrovirus-like particles and retroviral vaccines | |
| CA2538840C (en) | Dna vaccine compositions and methods of use | |
| EP0472706B1 (en) | Induction of protection against viral infection | |
| CA2339850C (en) | A non-cytolytic recombinant hiv-1 vaccine | |
| EP0613378A1 (en) | Induction of protection against viral infection by synergy between viral proteins and viral peptides | |
| ES2396915T3 (es) | Secuencias consenso, antígenos y transgenes del VIH-1 del clado A | |
| EP2788372B1 (en) | Mutated lentiviral env proteins and their use as drugs | |
| Armand et al. | Targeted expression of HTLV-I envelope proteins in muscle by DNA immunization of mice | |
| WO2005051419A1 (en) | Retrovirus-like particles and retroviral vaccines | |
| WO1994012513A1 (en) | Aids therapeutics based on hiv ma peptides |